- Meeting abstract
- Open Access
The permanently charged lidocaine analogue QX222 acts as a blocker from the intracellular side and as an inactivation modulator from the extracellular side in a mutant NaV1.4 channel
BMC Pharmacology volume 10, Article number: A24 (2010)
QX222 is a quaternary amine analogue of lidocaine, which, unlike lidocaine, is permanently charged. Lidocaine has its binding site in the internal vestibule of the voltage-gated sodium channel. Due to the hydrophobic nature of its uncharged form, lidocaine reaches the binding site by passing through the membrane, QX222 can reach this binding site only by a hydrophilic pathway, presumably through the channel protein. However, such a pathway has been reported only in the heart-type sodium channel (NaV1.5) and some mutants of other sodium channels. Notably, mutations at site 1575 in the skeletal muscle-type sodium channel (NaV1.4) open an access pathway from the external side. In this study we tested the properties of QX222 block on the mutant I1575E.
All measurements were done in tsA201 cells transiently transfected with the NaV1.4 sodium channel α subunit, cotransfected with β1 sodium channel subunit. Currents were recorded by patch-clamp technique in whole-cell configuration.
Both 500 μM lidocaine and 500 μM QX222 shifted the half-point of steady-state slow inactivation to hyperpolarized potentials in I1575E if applied from the extracellular side. However, only lidocaine significantly shifted the half-point of steady-state fast inactivation. Intracellular application of QX222 resulted in a quick block of sodium current, indicating that the drug entered the channel, but the hyperpolarizing shift of steady-state fast inactivation was still not present. In addition, with intracellular application of QX222, the strong hyperpolarizing shift in steady-state slow inactivation disappeared.
These results suggest that the binding site for use-dependent block is in the inner vestibule of the channel, that fast inactivation is modulated only by the hydrophobic form of local anaesthetics, and that the binding site for modulation of slow inactivation is only accessible form the extracellular side of the channel.
This work was supported by grants P21006-B11, P17509-B11, P13961-B05 from the FWF.
About this article
Cite this article
Lukács, P., Cervenka, R., Koenig, X. et al. The permanently charged lidocaine analogue QX222 acts as a blocker from the intracellular side and as an inactivation modulator from the extracellular side in a mutant NaV1.4 channel. BMC Pharmacol 10 (Suppl 1), A24 (2010). https://doi.org/10.1186/1471-2210-10-S1-A24
- Sodium Channel
- Extracellular Side
- Intracellular Application
- Hyperpolarizing Shift